Methods Of Treating Ankylosing Spondylitis Or Psoriatic Arthritis Using Anti-Il-17 Antibodies

Patent No. EP3111954 (titled "Methods Of Treating Ankylosing Spondylitis Or Psoriatic Arthritis Using Anti-Il-17 Antibodies") was filed by Novartis on Nov 4, 2011. The application was issued on Apr 3, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BOULT WADE TENNANTJan 3, 2020BOULT WADE TENNANT
DR REDDYS LABORATORIESJan 2, 2020MAIWALD
STRAWMANJan 2, 2020D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3111954

NOVARTIS
Application Number
EP16163440A
Filing Date
Nov 4, 2011
Status
Revoked
Dec 15, 2023
Publication Date
Apr 3, 2019